中国药物警戒 ›› 2012, Vol. 9 ›› Issue (5): 297-298.

• 管理及工作研究 • 上一篇    下一篇

浅析消痔灵注射液治疗痔疮的安全性风险

杨乐   

  1. 国家食品药品监督管理局药品评价中心，北京 100045
  • 收稿日期:2012-02-16 出版日期:2012-05-10 发布日期:2015-08-10
  • 作者简介:杨乐，男，主管药师，药品不良反应监测与评价。

Safty and Risk Analysis of Xiaozhiling Injection

YANG Le   

  1. Center for Drug Reevaluation, SFDA, Beijing 100045, China
  • Received:2012-02-16 Online:2012-05-10 Published:2015-08-10

PDF (PC)

614

摘要： 通过对消痔灵注射液安全性相关的国内文献报道、安全性研究状况进行分析，评价消痔灵注射液上市后的安全性情况及风险特点，提出符合药品本身特点的风险控制措施，为安全、合理使用该药提供建议。

关键词: 消痔灵注射液, 安全性风险, 风险控制, 措施

Abstract: By reviewing the relevant references and reports of the adverse drug reaction cases of Xiaozhiling in China, and analyzing the post marketing safety studies, the safety and risks in post-marketing period of Xiaozhiling is reevaluated in this article. The author puts forward risk management measures according to the characteristics of medicine. Suggestions are proposed for a safe and rational use of this medicine.

Key words: Xiaozhiling Injection, safety and risk, risk control, measure